2 Examples of PubMed MEDLINE format
                    (marked in Arrowsmith as the FIELDTAG format)

UI  - 89116243
PMID- 2536517
DA  - 19890301
DCOM- 19890301
LR  - 20001218
IS  - 0002-9343
VI  - 86
IP  - 2
DP  - 1989 Feb
TI  - Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a
      double-blind, controlled, prospective study.
PG  - 158-64
AB  - PURPOSE: The ingestion of omega-3 fatty acids could benefit patients with
      Raynaud's phenomenon because, among other effects, these fatty acids
      induce a favorable vascular response to ischemia. The aim of our study was
      to investigate, in a double-blind, placebo-controlled manner, the effects
      of fish-oil fatty-acid dietary therapy in patients with rheumatic disease.
      PATIENTS AND METHODS: Thirty-two patients with primary or secondary
      Raynaud's phenomenon were randomly assigned to olive-oil placebo or
      fish-oil groups. Patients ingested 12 fish-oil capsules daily containing a
      total of 3.96 g eicosapentaenoic acid and 2.64 g docosahexaenoic acid or
      12 olive-oil capsules and were evaluated at baseline and after six, 12,
      and 17 weeks. All patients ingested olive oil between Weeks 12 to 17.
      Digital systolic blood pressures and blood flow were measured at room air
      and water baths of 40 degrees C, 25 degrees C, 15 degrees C, and 10
      degrees C using strain gauge plethysmography. Onset of Raynaud's
      phenomenon was timed with a stop watch and defined as plethysmographic
      evidence of cessation of blood flow and blood pressure in the study
      finger. RESULTS: In the fish-oil group, the median time interval before
      the onset of Raynaud's phenomenon increased from 31.3 +/- 1.3 minutes
      baseline to 46.5 +/- 2.1 minutes at six weeks (p = 0.04). Patients with
      primary Raynaud's phenomenon ingesting fish oil had the greatest increase
      in the time interval before the onset of the condition. Five of 11
      patients (45.5 percent) with primary Raynaud's phenomenon ingesting fish
      oil in whom the phenomenon was induced at baseline could not be induced to
      develop Raynaud's at the six- or 12-week visit compared with one of nine
      patients (11 percent) with primary Raynaud's ingesting olive oil (p =
      0.05). The mean digital systolic pressures were higher in the patients
      with primary Raynaud's phenomenon ingesting fish oil than in patients with
      primary Raynaud's ingesting olive oil in the 10 degrees C water bath (+32
      mm Hg, p = 0.02). CONCLUSION: We conclude that the ingestion of fish oil
      improves tolerance to cold exposure and delays the onset of vasospasm in
      patients with primary, but not secondary, Raynaud's phenomenon. These
      improvements are associated with significantly increased digital systolic
      blood pressures in cold temperatures.
AD  - Division of Rheumatology, Albany Medical College, New York 12208.
FAU - DiGiacomo, R A
AU  - DiGiacomo RA
FAU - Kremer, J M
AU  - Kremer JM
FAU - Shah, D M
AU  - Shah DM
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Randomized Controlled Trial
CY  - UNITED STATES
TA  - Am J Med
JID - 0267200
RN  - 0 (Placebos)
RN  - 1553-41-9 (5,8,11,14,17-Eicosapentaenoic Acid)
RN  - 25167-62-8 (Docosahexaenoic Acids)
SB  - AIM
SB  - IM
MH  - 5,8,11,14,17-Eicosapentaenoic Acid/*therapeutic use
MH  - Adult
MH  - Aged
MH  - Blood Pressure
MH  - Clinical Trials
MH  - Docosahexaenoic Acids/*therapeutic use
MH  - Double-Blind Method
MH  - Female
MH  - Fingers/blood supply
MH  - Human
MH  - Male
MH  - Middle Age
MH  - Placebos
MH  - Prospective Studies
MH  - Raynaud's Disease/*diet therapy/etiology/physiopathology
MH  - Regional Blood Flow
MH  - Scleroderma, Systemic/complications
EDAT- 1989/02/01
MHDA- 1989/02/01 00:01
PST - ppublish
SO  - Am J Med 1989 Feb;86(2):158-64.

UI  - 87091483
PMID- 3797213
DA  - 19870218
DCOM- 19870218
LR  - 20001218
IS  - 0031-5982
VI  - 30
IP  - 1
DP  - 1986 Autumn
TI  - Fish oil, Raynaud's syndrome, and undiscovered public knowledge.
PG  - 7-18
FAU - Swanson, D R
AU  - Swanson DR
LA  - eng
PT  - Journal Article
CY  - UNITED STATES
TA  - Perspect Biol Med
JID - 0401132
RN  - 0 (Fish Oils)
SB  - IM
MH  - Animal
MH  - Blood Platelets/drug effects/*physiology
MH  - Blood Vessels/drug effects/*physiology/physiopathology
MH  - Blood Viscosity/*drug effects
MH  - Fish Oils/pharmacology/*therapeutic use
MH  - Human
MH  - Raynaud's Disease/diet therapy/*physiopathology
MH  - Vascular Diseases/*prevention & control
EDAT- 1986/01/01
MHDA- 1986/01/01 00:01
PST - ppublish
SO  - Perspect Biol Med 1986 Autumn;30(1):7-18.